Presence of immunoreactive corticotropin-releasing hormone in human endometrium

G Mastorakos1, C D Scopa, L C Kao

  • 1Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Corticotropin-releasing hormone (CRH) is present in the human endometrium, particularly in glandular cells. This finding suggests CRH may play a role in endometrial processes like repair and implantation.

Area of Science:

  • Reproductive Endocrinology
  • Immunology
  • Cell Biology

Background:

  • Immunoreactive corticotropin-releasing hormone (IrCRH) is produced locally in inflammatory conditions and by reproductive organs.
  • CRH is secreted in vitro by human endometrial cells, suggesting a potential role in endometrial physiology.

Purpose of the Study:

  • To investigate the presence and localization of CRH in the human endometrium in vivo.
  • To explore the potential role of endometrial CRH in physiological processes.

Main Methods:

  • Immunohistochemistry and extraction/radioimmunoassay (RIA) were used to detect IrCRH in endometrial biopsies from 33 women.
  • Reverse-phase high-pressure liquid chromatography was employed to analyze the molecular properties of endometrial CRH.

Main Results:

  • Intense IrCRH staining was observed in the cytoplasm of endometrial glandular cells across all menstrual cycle stages.
  • IrCRH was also detected in decidualized stromal cells and local immune accessory cells.
  • Endometrial CRH molecule characteristics were similar to rat/human CRH.

Conclusions:

  • The presence of CRH in the human endometrium, especially glandular epithelium, supports its role in inflammatory-like endometrial processes.
  • CRH may be involved in menstrual shedding, epithelial repair, and blastocyst implantation.
  • CRH in decidualized stromal cells aligns with previous in vitro findings and placental CRH production.

Related Concept Videos

Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...